Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Queen's University at Kingston has 7 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 7 distinct examiners and 7 distinct art units, showing complete separation across the recorded examiner and unit assignments.
PEREZ BORROTO, ALFONSO is the busiest examiner, with 1 pending matter. Since no examiner has multiple pending matters in the data, prosecution management is best organized by application, with portfolio-level coordination used to preserve consistent positions where technologies overlap.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (14%) |
| Multi-statute (no §101) | 6 (86%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCANANY, JOHN D | 1 | 65.1% | +46.4% |
| AHMAD, SHAHZEB K | 1 | 79.6% | +4.6% |
| BLAISE, BRADFORD CHRISTOPHER | 1 | 60.5% | +31.4% |
| HOEKSTRA, JEFFREY GERBEN | 1 | 56.1% | +39.8% |
| PAULUS, ERIN VIRGINIA | 1 | 20.0% | +94.1% |
| PHAN, DOAN THI-THUC | 1 | 42.8% | +47.6% |
| EPPERT, LUCY CLARE | 1 | 55.0% | +37.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18029260 | Method and Apparatus for Generating an Electrocardiogram from a Photoplethysmogram | EPPERT, LUCY CLARE | 30d |
| 19024516 | Apoptosis Inhibitors | MCANANY, JOHN D | — |
| 18874794 | Power Factor Correction with Power Balancing Control for Three-Phase Single-Stage AC-DC Converters | AHMAD, SHAHZEB K | — |
| 18633882 | Wireless Intraocular Pressure Sensor | HOEKSTRA, JEFFREY GERBEN | — |
| 18561772 | Combination Therapy Tumour Cell Vaccine | PAULUS, ERIN VIRGINIA | — |
| 18142878 | Synthetic Implantable Composition with Immunomodulatory Properties | PHAN, DOAN THI-THUC | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18660720 | Adhesive Wearable Sensors for Measuring Bioelectrical Signals | BLAISE, BRADFORD CHRISTOPHER | 21d |
| 18029260 | Method and Apparatus for Generating an Electrocardiogram from a Photoplethysmogram | EPPERT, LUCY CLARE | 30d |
| 19024516 | Apoptosis Inhibitors | MCANANY, JOHN D | — |
| 18633882 | Wireless Intraocular Pressure Sensor | HOEKSTRA, JEFFREY GERBEN | — |
| 18561772 | Combination Therapy Tumour Cell Vaccine | PAULUS, ERIN VIRGINIA | — |
| 18142878 | Synthetic Implantable Composition with Immunomodulatory Properties | PHAN, DOAN THI-THUC | — |
| Art Unit | Apps |
|---|---|
| 3791 | 2 |
| 1625 | 1 |
| 2838 | 1 |
| 3794 | 1 |
| 1631 | 1 |
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19024516 | Apoptosis Inhibitors | MCANANY, JOHN D | 1625 | §102§103§112 | Non-Final OA | — | Pending | Jan 16, 2025 |
| 18874794 | Power Factor Correction with Power Balancing Control for Three-Phase Single-Stage AC-DC Converters | AHMAD, SHAHZEB K | 2838 | §102§103§112 | Non-Final OA | — | Pending | Dec 13, 2024 |
| 18660720 | Adhesive Wearable Sensors for Measuring Bioelectrical Signals | BLAISE, BRADFORD CHRISTOPHER | 3794 | §103 | Final Rejection | 21d | Pending | May 10, 2024 |
| 18633882 | Wireless Intraocular Pressure Sensor | HOEKSTRA, JEFFREY GERBEN | 3791 | §102§103 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18561772 | Combination Therapy Tumour Cell Vaccine | PAULUS, ERIN VIRGINIA | 1631 | §102§103§112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18142878 | Synthetic Implantable Composition with Immunomodulatory Properties | PHAN, DOAN THI-THUC | 1613 | §102§103§112 | Non-Final OA | — | Pending | May 03, 2023 |
| 18029260 | Method and Apparatus for Generating an Electrocardiogram from a Photoplethysmogram | EPPERT, LUCY CLARE | 3791 | §102§103§112 | Final Rejection | 30d | Pending | Mar 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialQueen's University at Kingston has 7 pending office actions as of October 2026, spread across 6 art units and 7 examiners.
John D Mcanany has the most, with 1 of Queen's University at Kingston's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
